Literature DB >> 12453630

Variation of variable number of tandem repeat sequences in the 3'-untranslated region of primate dopamine transporter genes that affects reporter gene expression.

Miho Inoue-Murayama1, Satomi Adachi, Noriko Mishima, Hiroaki Mitani, Osamu Takenaka, Keiji Terao, Ikuo Hayasaka, Shin'ichi Ito, Yuichi Murayama.   

Abstract

Genetic polymorphism has been reported in the 3'-untranslated region (3'-UTR) of the human dopamine transporter (DAT) gene and the variable number of tandem repeat (VNTR) polymorphism has been proposed to be associated with normal personal traits or psychoneurological disorders. To assess the variation of this region in nonhuman primates, we amplified the VNTR regions by the polymerase chain reaction in several species of apes and monkeys, and determined their DNA sequences. The 3'-UTR of the chimpanzee DAT gene was also polymorphic and alleles with one or two unit(s) of a 40 bp sequence were found, while all gorillas and orangutans examined had only 2-repeat allele. Cynomolgus macaques and African green monkeys shared 11- or 12-repeat and 5-repeat alleles, respectively. By performing transient transfection assay, we found that most of the VNTR sequences of nonhuman primates exhibited higher activities on reporter gene assay as compared to those of human 9-, 10- and 11-repeat sequences.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12453630     DOI: 10.1016/s0304-3940(02)01125-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  25 in total

1.  Dopamine Genetics and Function in Food and Substance Abuse.

Authors:  K Blum; M Oscar-Berman; D Barh; J Giordano; Ms Gold
Journal:  J Genet Syndr Gene Ther       Date:  2013-02-10

2.  Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects.

Authors:  Thomas J Spencer; Joseph Biederman; Stephen V Faraone; Bertha K Madras; Ali A Bonab; Darin D Dougherty; Holly Batchelder; Allison Clarke; Alan J Fischman
Journal:  Biol Psychiatry       Date:  2012-12-27       Impact factor: 13.382

3.  Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors.

Authors:  Nao J Gamo; Min Wang; Amy F T Arnsten
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-09-01       Impact factor: 8.829

4.  Common human 5' dopamine transporter (SLC6A3) haplotypes yield varying expression levels in vivo.

Authors:  Tomas Drgon; Zhicheng Lin; Gene-Jack Wang; Joanna Fowler; Johnfn Pablo; Deborah C Mash; Nora Volkow; George R Uhl
Journal:  Cell Mol Neurobiol       Date:  2006-05-20       Impact factor: 5.046

5.  Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.

Authors:  Joseph P Schacht; Raymond F Anton; Konstantin E Voronin; Patrick K Randall; Xingbao Li; Scott Henderson; Hugh Myrick
Journal:  Neuropsychopharmacology       Date:  2012-10-03       Impact factor: 7.853

Review 6.  Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence.

Authors:  Andreas Heinz; David Goldman; Jürgen Gallinat; Gunter Schumann; Imke Puls
Journal:  Psychopharmacology (Berl)       Date:  2004-05-18       Impact factor: 4.530

7.  Polymorphism of the 3'-UTR of the dopamine transporter gene (DAT) in New World monkeys.

Authors:  Marco Lucarelli; Elisabetta Visalberghi; Walter Adriani; Elsa Addessi; Silvia Pierandrei; Arianna Manciocco; Francesca Zoratto; Andrea Tamellini; Augusto Vitale; Giovanni Laviola; Jessica Lynch Alfaro; Esterina Pascale
Journal:  Primates       Date:  2016-08-08       Impact factor: 2.163

Review 8.  Molecular genetics of monoamine transporters: relevance to brain disorders.

Authors:  K Haddley; A S Vasiliou; F R Ali; U M Paredes; V J Bubb; J P Quinn
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

9.  Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis.

Authors:  S V Faraone; T J Spencer; B K Madras; Y Zhang-James; J Biederman
Journal:  Mol Psychiatry       Date:  2013-09-24       Impact factor: 15.992

10.  SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Authors:  Elizabeth M Azzato; Lindsay M Morton; Andrew W Bergen; Sophia S Wang; Nilanjan Chatterjee; Paul Kvale; Meredith Yeager; Richard B Hayes; Stephen J Chanock; Neil E Caporaso
Journal:  BMC Med Genet       Date:  2009-01-30       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.